Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.
Listing ID:
44498920359
Licence(s) Held:
The platform is in formation and targeting a full suite of UK regulatory authorisations under MHRA, Home Office, GPhC, and CQC regulatory frameworks. This includes manufacturing licenses (MS), distribution licenses (WDA (H) and Controlled Drug) as well as online Clinic and Pharmacy. The suite of licences will permit regulated import, storage, distribution, dispensing, and prescription of Medical Cannabis and other ‘Specials’ medicines, including adjacent therapeutic categories such as GLP-1 treatments.
Seeking strategic equity investment and/or structured debt to support licensing, regulatory approvals, and platform build-out. Further details available upon request.
Listing Details:
Pre-Operational Platform: Early-stage opportunity to back the formation of a UK regulated Medical Cannabis operating platform prior to revenue generation.
Regulatory Pathway Defined: Structured approach to securing MHRA, Home Office, GPhC, and CQC approvals to establish a compliant pharmaceutical supply chain.
Experienced Operator-Led Build: Led by a seasoned medical cannabis entrepreneur with direct UK sector experience, supported by a highly experienced regulatory and operational execution team to drive initial sales.
Commercial Focus: Set to capture 86% of the Medical Cannabis Value Chain, everything except the cultivation.
Market Tailwinds: Positioned within a growing UK medical cannabis and Specials medicines market driven by expanding private clinic adoption and chronic care demand. Now in its eighth year, the UK market has become highly attractive as the world's fourth largest and fastest growing, with the highest current retail prices and high further growth potential in this country of 70 million people.
Scalable Platform Potential: The business will form an integrated supply chain from import to patient.
Strategic Exit Potential: Long-term acquisition interest from pharmaceutical, healthcare, and international cannabis operators seeking UK market entry.
Tax Efficiency: Potential eligibility for UK EIS/SEIS tax relief, subject to investor qualification and final structure.
44498920359
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
55606342051
Fully Licensed German Medical Cannabis Wholesaler & Importer with EU-GMP warehouse for 500k EUR
An exceptional opportunity to acquire 100% of an established German GmbH specifically structured for the high-growth medical cannabis sector. The entity offers a lean, highly scalable infrastructure with all critical operational pillars—including a licensed packing/storage warehouse, fully verified GMP/GDP compliance, strategic supply chain partnerships, and advanced quality technology—positioned for immediate market acceleration.
28971289009
Court-Approved Sale & Investment Solicitation – Noble Growth Corp. & Noble Growth Alberta LP
Opportunity to acquire, invest in, restructure, or refinance a licensed cannabis cultivation, processing, branded products, & medical cannabis platform through a Court-approved Sale & Investment Solicitation Process (SISP). This offering provides a potential "clean slate" entry into the Canadian & global cannabis markets through a debt-free acquisition structure.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o